Gabriel Lázaro-Muñoz, PhD, JD

Gabriel Lázaro-Muñoz, PhD, JD, is Associate Professor at Harvard Medical School with appointments in Neurosurgery and Psychiatry at Mass General Brigham and the HMS Center for Bioethics. He leads the Brain Bioethics Lab at MGB Neurosurgery and co-directs the Neurotech Justice Accelerator at MGB (NJAM), a Dana Center for Neuroscience & Society. He is founder of Fidelia, which builds certification standards for health technologies including neurotechnology, genomics, clinical AI, and digital health.

Dr. Lázaro-Muñoz integrates training in neuroscience, law, and bioethics to examine the ethical, legal, and policy implications of emerging biotechnologies. His work uses embedded approaches - participant-observation, stakeholder interviews, surveys, and policy analysis - to translate empirical findings into actionable policy and certifiable standards. As principal investigator, he has secured more than $25 million in funding, including seven R01 awards from the BRAIN Initiative, NIMH, NHGRI, and NIDA. His current studies examine psychiatric genetics, polygenic embryo screening, polygenic scores for substance use disorders, neurotechnology (e.g., BCI, DBS), and how to build the infrastructure to support the delivery of biotechnologies to patients who can benefit. He has published over 125 manuscripts. He serves on the NIH-NHGRI Genomics & Society Working Group, the International Brain Initiative Neuroethics Working Group, and the editorial board of Genetics in Medicine. His work has been featured in Nature, STAT, NPR, the Associated Press, and MIT Technology Review. He received his PhD in Neuroscience (NYU), JD and Master of Bioethics (University of Pennsylvania), and BA in Psychology (University of Puerto Rico).